Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer

Showing 15 posts of 262 posts found.

bayercross3

FDA approves Bayer haemophilia A drug Kovaltry

March 17, 2016
Research and Development, Sales and Marketing Bayer, FDA, approval, drug, drug approval, haemophilia, haemophilia a, kovaltry, viii compound

Bayer (ETR:BAYN) has received approval from the US Food and Drug Administration (FDA) for Kovaltry (octocog alfa), an unmodified, full-length …

News
bayercross3

Bayer to collaborate on new treatments for tuberculosis with Universities of Dundee, Cape Town

March 8, 2016
Manufacturing and Production, Research and Development Bayer, TB, tuberculosis, university of cape town, university of dundee

The pharmaceuticals division at German-based Bayer will collaborate with the renowned medicinal chemistry and biology departments at the Universities of …

News
baumann_bayer

Bayer names Werner Baumann new CEO

February 26, 2016
Medical Communications Bayer

Werner Baumann will become the new chief executive of Bayer AG from May 1, the company has announced. The decision …

Appointment

Europe approves Bayer haemophilia drug

February 22, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, haemophilia a

Bayer has received approval from the European Commission for its haemophilia A drug Kovaltry (octocog alfa) in patients of all …

News
Xarelto

Investigation questions Xarelto trial data accuracy

February 4, 2016
Medical Communications BMJ, Bayer, INR, Johnson & Johnson, New England Journal of Medicine, Rocket-AF, Xarelto, blood clotting, rivaroxaban

The ROCKET-AF trial, the pivotal trial of the top-selling anti-clotting drug Xarelto, could have been undermined by unreliable results from …

News
China manufacturing

Bayer opens OTC drug plant in China

January 19, 2016
Manufacturing and Production Bayer, China, OTC, TCM, Yunnan, over the counter, traditional Chinese medicine

Bayer has opened a new manufacturing plant to produce over-the-counter (OTC) drugs in China, as the German firm looks to …

News
Baxalta logo

Bayer and Baxalta in separate €1 billion-plus deals

January 5, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Ascensia diabetes care, Baxalta, Bayer, diabetes, panasonic, symphogen

Baxalta has signed a deal with Symphogen potentially worth as much as €1.4 billion, under which the companies will develop …

News
ASH 2014 meeting

Bayer and Novartis to debut new data at ASH 2015

November 30, 2015
Research and Development, Sales and Marketing American Society of Hematology, Bayer, Conference, Novartis, ash, clinical trials, haematology, oncology

Pharma firms will present clinical trial results for the pipeline drugs they are pinning their 2016 hopes for success on, …

News
abpi_code_of_practice_2011

Bayer takes on Actavis in ABPI code conduct breach

November 26, 2015
Medical Communications, Sales and Marketing ABPI, Actavis, Bayer, PMCPA

The Prescription Medicines Code of Practice Authority (PMCPA) has ruled in favour of Bayer in a case brought against Actavis. …

News
bayer_cross_2

NICE decision restricts Bayer’s Xofigo to select prostate cancer patients

November 19, 2015
Research and Development, Sales and Marketing Bayer, NICE, prostate cancer

NICE has issued its Final Appraisal Determination (FAD) recommending Bayer’s Xofigo (radium-223 dichloride) for use on the NHS in England …

News
Proteus Digital and Otuska's 'digital pill'

The ‘Pharmasaurus’ aims to evolve into a leader in the digital age

November 12, 2015
Medical Communications, Research and Development Bayer, Roche, digital health, pharma

Pharma’s new-found willingness to embrace all aspects of the digital age, and use it both to its advantage and that …

Feature
eylea

Bayer, Regeneron’s Eylea gets additional EU indication

November 2, 2015
Research and Development, Sales and Marketing Bayer, Eylea, Regeneron

The European Commission has granted a fifth indication to Bayer and Regeneron’s eye drug Eylea (aflibercept injection), which is now …

News
Xarelto

Bayer backs safety of Xarelto after real-world data study

September 2, 2015
Research and Development Bayer, ESC, European Society of Cardiology, Xarelto, anticoagulants, atrial fibrillation, real-word evidence, rivaroxaban

Around 96 in every 100 people treated with Bayer’s anticoagulant Xarelto do not experience any major bleeding, related side effects …

News
Code of Practice

Bayer’s complaint over ‘misleading’ Novartis eye drug claims upheld

August 14, 2015
Medical Communications Bayer, Eylea, Lucentis, Novartis, PMCPA, code of conduct

The industry’s code of conduct regulator has ruled in favour of Bayer in a dispute claims made by Novartis when …

News
Bayer's Alexander Moscho

Working Life: Bayer UK & Ireland’s chief executive Alexander Moscho

July 6, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, Bayer

How did you find your way into your current role?I think it started when I was young and I was …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025